Pharmacotherapics Advice in Guidelines for COVID-19

Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhang-Ren, Zhou, Ying, Liu, Jin, Peng, Hong-Wei, Zhou, Jian, Zhong, Hai-Li, Liu, Li-Li, Lai, Ming-Fang, Wei, Xiao-Hua, Wen, Jin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327107/
https://www.ncbi.nlm.nih.gov/pubmed/32670066
http://dx.doi.org/10.3389/fphar.2020.00950
_version_ 1783552474520485888
author Chen, Zhang-Ren
Zhou, Ying
Liu, Jin
Peng, Hong-Wei
Zhou, Jian
Zhong, Hai-Li
Liu, Li-Li
Lai, Ming-Fang
Wei, Xiao-Hua
Wen, Jin-Hua
author_facet Chen, Zhang-Ren
Zhou, Ying
Liu, Jin
Peng, Hong-Wei
Zhou, Jian
Zhong, Hai-Li
Liu, Li-Li
Lai, Ming-Fang
Wei, Xiao-Hua
Wen, Jin-Hua
author_sort Chen, Zhang-Ren
collection PubMed
description Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs.
format Online
Article
Text
id pubmed-7327107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73271072020-07-14 Pharmacotherapics Advice in Guidelines for COVID-19 Chen, Zhang-Ren Zhou, Ying Liu, Jin Peng, Hong-Wei Zhou, Jian Zhong, Hai-Li Liu, Li-Li Lai, Ming-Fang Wei, Xiao-Hua Wen, Jin-Hua Front Pharmacol Pharmacology Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs. Frontiers Media S.A. 2020-06-24 /pmc/articles/PMC7327107/ /pubmed/32670066 http://dx.doi.org/10.3389/fphar.2020.00950 Text en Copyright © 2020 Chen, Zhou, Liu, Peng, Zhou, Zhong, Liu, Lai, Wei and Wen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Chen, Zhang-Ren
Zhou, Ying
Liu, Jin
Peng, Hong-Wei
Zhou, Jian
Zhong, Hai-Li
Liu, Li-Li
Lai, Ming-Fang
Wei, Xiao-Hua
Wen, Jin-Hua
Pharmacotherapics Advice in Guidelines for COVID-19
title Pharmacotherapics Advice in Guidelines for COVID-19
title_full Pharmacotherapics Advice in Guidelines for COVID-19
title_fullStr Pharmacotherapics Advice in Guidelines for COVID-19
title_full_unstemmed Pharmacotherapics Advice in Guidelines for COVID-19
title_short Pharmacotherapics Advice in Guidelines for COVID-19
title_sort pharmacotherapics advice in guidelines for covid-19
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327107/
https://www.ncbi.nlm.nih.gov/pubmed/32670066
http://dx.doi.org/10.3389/fphar.2020.00950
work_keys_str_mv AT chenzhangren pharmacotherapicsadviceinguidelinesforcovid19
AT zhouying pharmacotherapicsadviceinguidelinesforcovid19
AT liujin pharmacotherapicsadviceinguidelinesforcovid19
AT penghongwei pharmacotherapicsadviceinguidelinesforcovid19
AT zhoujian pharmacotherapicsadviceinguidelinesforcovid19
AT zhonghaili pharmacotherapicsadviceinguidelinesforcovid19
AT liulili pharmacotherapicsadviceinguidelinesforcovid19
AT laimingfang pharmacotherapicsadviceinguidelinesforcovid19
AT weixiaohua pharmacotherapicsadviceinguidelinesforcovid19
AT wenjinhua pharmacotherapicsadviceinguidelinesforcovid19

Ejemplares similares